These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 16672699)
1. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. Schillinger M; Sabeti S; Loewe C; Dick P; Amighi J; Mlekusch W; Schlager O; Cejna M; Lammer J; Minar E N Engl J Med; 2006 May; 354(18):1879-88. PubMed ID: 16672699 [TBL] [Abstract][Full Text] [Related]
2. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
3. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR; Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101 [TBL] [Abstract][Full Text] [Related]
4. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. Kickuth R; Keo HH; Triller J; Ludwig K; Do DD J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131 [TBL] [Abstract][Full Text] [Related]
5. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Schillinger M; Sabeti S; Dick P; Amighi J; Mlekusch W; Schlager O; Loewe C; Cejna M; Lammer J; Minar E Circulation; 2007 May; 115(21):2745-9. PubMed ID: 17502568 [TBL] [Abstract][Full Text] [Related]
6. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Krankenberg H; Schlüter M; Steinkamp HJ; Bürgelin K; Scheinert D; Schulte KL; Minar E; Peeters P; Bosiers M; Tepe G; Reimers B; Mahler F; Tübler T; Zeller T Circulation; 2007 Jul; 116(3):285-92. PubMed ID: 17592075 [TBL] [Abstract][Full Text] [Related]
7. Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. Schlager O; Dick P; Sabeti S; Amighi J; Mlekusch W; Minar E; Schillinger M J Endovasc Ther; 2005 Dec; 12(6):676-84. PubMed ID: 16363897 [TBL] [Abstract][Full Text] [Related]
8. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR; J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193 [TBL] [Abstract][Full Text] [Related]
9. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study. Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625 [TBL] [Abstract][Full Text] [Related]